Pedro, Saramago;
Mark, Rodgers;
Shainur, Premji;
Eleonora, Uphoff;
Minyue, Gao;
Helen, Fulbright;
Ana, Duarte;
+ view all
(2023)
Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments.
National Institute for Health and Care Excellence (NICE): UK.
Preview |
PDF
committee-papers-2.pdf - Published Version Download (12MB) | Preview |
| Type: | Report |
|---|---|
| Title: | Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments |
| Open access status: | An open access version is available from UCL Discovery |
| Publisher version: | https://www.nice.org.uk/guidance/ta927/history |
| Language: | English |
| Additional information: | Copyright content owned by the National Institute for Health and Care Excellence (NICE) is made available for reuse to individuals and commercial/non-commercial organisations on a non-exclusive basis in the United Kingdom only under the NICE UK Open Content Licence. See NICE UK Open Content Licence for specific terms and conditions. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health > Primary Care and Population Health |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10211941 |
Archive Staff Only
 |
View Item |
